Skip to content

R&D at other companies

Eli Lilly logo
Eli LillyLLY
$3.51B+28.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.54B+16.3%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$95.73M+35.0%
OS Therapies logo
OS TherapiesOSTX
$7.35M+462%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$19.24M+2.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$14.05M+54.0%

Segments

By product

See full
Antibody Drug Conjugate$12.04M
FYARRO$7K-99.9%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's R&D?
WHWK (WHWK) reported R&D of $17.23M in Q1 2026.
How has WHWK's R&D changed year-over-year?
WHWK's R&D increased by 96.1% year-over-year, from $8.79M to $17.23M.
What is the long-term trend for WHWK's R&D?
Over 3 years (2021 to 2025), WHWK's R&D has grown at a 66.6% compound annual growth rate (CAGR), from $19.67M to $90.96M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.